DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 49 · September 2016 DOI: 10.1055/s-006-32612

Original Paper

  • 177
    Yu, W.; Sun, X.; Li, Y.; Li, M.; Wang, K.; Li, H.:

    Population Pharmacokinetics of Lithium Carbonate in Young Male Healthy Chinese Volunteers

  • 182
    Kamei, K.; Terao, T.; Katayama, Y.; Hatano, K.; Kodama, K.; Shirahama, M.; Sakai, A.; Hirakawa, H.; Mizokami, Y.; Shiotsuki, I.; Ishii, N.; Inoue, Y.:

    A Predictive Model of Plasma Lamotrigine Levels

  • 186
    Berm, E.; Kok, R.; Hak, E.; Wilffert, B.:

    Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry

  • 191
    Huang, W.-L.; Liao, S.-C.; Kuo, T. B. J.; Chang, L.-R.; Chen, T.-T.; Chen, I.-M.; Yang, C. C. H.:

    The Effects of Antidepressants and Quetiapine on Heart Rate Variability

  • 199
    Müller, U. J.; Schuermann, F.; Dobrowolny, H.; Frodl, T.; Bogerts, B.; Mohr, S.; Steiner, J.:

    Assessment of Pharmacological Treatment Quality: Comparison of Symptom-triggered vs. Fixed-schedule Alcohol Withdrawal in Clinical Practice

    Supporting Information (PDF)
  • 204
    Sarubin, N.; Baghai, T. C.; Lima-Ojeda, J. M.; Melchner, D.; Hallof-Buestrich, H.; Wolf, L.; Hilbert, S.; Milenkovic, V. M.; Wetzel, C. H.; Rupprecht, R.; Nothdurfter, C.:

    Translocator Protein (TSPO) Expression in Platelets of Depressed Patients Decreases during Antidepressant Therapy

    • Letter to the Editor

  • 210
    Ng, C. H.; Bousman, C.; Smith, D. J.; Dowling, N.; Byron, K.; King, J.; Sarris, J.:

    A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder

  • 213
    Kamp, D.; Paschali, M.; Lange-Asschenfeldt, C.:

    Reversible Hypothermia in a Drug-naive Inpatient with Alzheimer’s Disease Receiving Pipamperone